Other health conditions: The presence of cardiovascular disease, kidney problems, or other conditions may influence the choice of GLP-1
Semaglutide: Ozempic, Wegovy, and the GLP-1 Revolution Semaglutide marketed as Ozempic for type 2 diabetes management and Wegovy for chronic weight management is a once-weekly injectable GLP-1 receptor agonist that has transformed the landscape of obesity medicine
Ive seen it firsthand: patients lose a significant amount of weight, then stop the medication about a year in
It is biology, a connected system that links cortisol, the gut microbiome, SCFAs, neurotransmitters, inflammation, and GLP-1, the hormone that helps signal fullness
Nuun Zero Sugar offers portable tablets that are easy to toss into a purse, gym bag, or desk drawer, making it easier to keep electrolytes on hand wherever the day takes you
JACC Cardiovascular Imaging 2011, 4: 630-637